Trials / Completed
CompletedNCT01400919
DURABILITY™ Iliac Study
Protege® EverFlex™ and GPS™ Self-Expanding Iliac Study (DURABILITY™ Iliac)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Medtronic Endovascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The DURABILITY Iliac study is a prospective, multi-center, non-randomized study confirming the safety and effectiveness of stenting using the Protégé® EverFlex™ and Protégé® GPS™ Self-Expanding Stent Systems for the treatment of atherosclerotic lesions in the common and/or external iliac arteries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Protégé® EverFlex™ Self-Expanding Stent System, and Protégé® GPS™ Self-Expanding Stent System. | Implantation of one or more study devices in the common and/or external iliac artery. |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2013-11-01
- Completion
- 2016-01-01
- First posted
- 2011-07-25
- Last updated
- 2018-03-07
- Results posted
- 2015-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01400919. Inclusion in this directory is not an endorsement.